- Home
- RGLS vs NTIC Comparison
RGLS vs NTIC Comparison
Compare RGLS & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLS
- NTIC
- Stock Information
- Founded
- RGLS 2007
- NTIC 1970
- Country
- RGLS United States
- NTIC United States
- Employees
- RGLS N/A
- NTIC N/A
- Industry
- RGLS Biotechnology: Pharmaceutical Preparations
- NTIC Industrial Specialties
- Sector
- RGLS Health Care
- NTIC Industrials
- Exchange
- RGLS Nasdaq
- NTIC Nasdaq
- Market Cap
- RGLS 102.8M
- NTIC 112.1M
- IPO Year
- RGLS 2012
- NTIC N/A
- Fundamental
- Price
- RGLS $1.59
- NTIC $12.53
- Analyst Decision
- RGLS Strong Buy
- NTIC Buy
- Analyst Count
- RGLS 6
- NTIC 1
- Target Price
- RGLS $10.33
- NTIC $20.00
- AVG Volume (30 Days)
- RGLS 278.0K
- NTIC 17.1K
- Earning Date
- RGLS 11-07-2024
- NTIC 07-11-2024
- Dividend Yield
- RGLS N/A
- NTIC 2.27%
- EPS Growth
- RGLS N/A
- NTIC 71.72
- EPS
- RGLS N/A
- NTIC 0.46
- Revenue
- RGLS N/A
- NTIC $82,420,045.00
- Revenue This Year
- RGLS N/A
- NTIC $7.49
- Revenue Next Year
- RGLS N/A
- NTIC $11.52
- P/E Ratio
- RGLS N/A
- NTIC $26.79
- Revenue Growth
- RGLS N/A
- NTIC 3.74
- 52 Week Low
- RGLS $1.08
- NTIC $10.08
- 52 Week High
- RGLS $3.79
- NTIC $19.63
- Technical
- Relative Strength Index (RSI)
- RGLS 47.92
- NTIC 45.87
- Support Level
- RGLS $1.47
- NTIC $11.81
- Resistance Level
- RGLS $1.65
- NTIC $13.10
- Average True Range (ATR)
- RGLS 0.10
- NTIC 0.50
- MACD
- RGLS 0.00
- NTIC -0.01
- Stochastic Oscillator
- RGLS 48.84
- NTIC 36.00
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.